Christopher Doran

Summary

Affiliation: University of Queensland
Country: Australia

Publications

  1. ncbi The consumption of alcohol by Australian adolescents: a comparison of revenue and expenditure
    Christopher M Doran
    School of Population Health, University of Queensland, Australia
    Addict Behav 31:1919-28. 2006
  2. ncbi Smoking status of Australian general practice patients and their attempts to quit
    Christopher M Doran
    School of Population Health, School of Economics, University of Queensland, Public Health Building, Herston Road, Herston QLD 4006, Australia
    Addict Behav 31:758-66. 2006
  3. ncbi General practitioners' role in preventive medicine: scenario analysis using alcohol as a case study
    Christopher M Doran
    School of Population Health University of Queensland, Australia
    Drug Alcohol Rev 23:399-404. 2004
  4. ncbi A cost-effectiveness analysis of buprenorphine-assisted heroin withdrawal
    C M Doran
    School of Population Health, University of Queensland, Herston, Australia
    Drug Alcohol Rev 23:171-5. 2004
  5. ncbi Use of pharmacotherapies for the management of addictive behaviours in Australian clinical practice
    Christopher M Doran
    School of Population Health, School of Economics, University of Queensland, Mayne Medical Building, Herston Road, Herston QLD 4006, Australia
    Addict Behav 31:1947-58. 2006
  6. ncbi Characteristics of Australian smokers using bupropion and nicotine-replacement therapies
    Christopher Doran
    Associate Professor, School of Economics, University of Queensland School of Population Health Mayne Medical Building, Herston Road, Herston Qld, 4006, Australia
    Expert Rev Pharmacoecon Outcomes Res 7:41-7. 2007
  7. ncbi Cost-effectiveness analysis of maintenance agonist treatments in the NEPOD
    Christopher M Doran
    Associate Professor, Health Economist, University of Queensland, School of Population Health, School of Economics, Mayne Medical School, Herston Road, Herston 4006, QLD, Australia
    Expert Rev Pharmacoecon Outcomes Res 6:437-46. 2006
  8. ncbi Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05
    Hera Lutsenko
    School of Population Health, University of Queensland, Australia
    Drug Alcohol Rev 27:160-4. 2008
  9. ncbi How can we reduce alcohol-related road crash deaths among young Australians?
    Wayne D Hall
    School of Population Health, University of Queensland, Brisbane, QLD, Australia
    Med J Aust 192:464-6. 2010
  10. ncbi Cost-effectiveness analysis of genetic screening for the Taq1B polymorphism in the secondary prevention of coronary heart disease
    Linda K Kemp
    The University of Queensland, School of Population Health, Mayne Medical School, Herston Road, Herston 4006, QLD, Australia
    Expert Rev Pharmacoecon Outcomes Res 7:119-28. 2007

Detail Information

Publications20

  1. ncbi The consumption of alcohol by Australian adolescents: a comparison of revenue and expenditure
    Christopher M Doran
    School of Population Health, University of Queensland, Australia
    Addict Behav 31:1919-28. 2006
    ....
  2. ncbi Smoking status of Australian general practice patients and their attempts to quit
    Christopher M Doran
    School of Population Health, School of Economics, University of Queensland, Public Health Building, Herston Road, Herston QLD 4006, Australia
    Addict Behav 31:758-66. 2006
    ....
  3. ncbi General practitioners' role in preventive medicine: scenario analysis using alcohol as a case study
    Christopher M Doran
    School of Population Health University of Queensland, Australia
    Drug Alcohol Rev 23:399-404. 2004
    ..The knowledge, skill and attitude of practitioners toward drinking are significant, and they can be the prime motivators in persuading their patients to modify drinking behaviour...
  4. ncbi A cost-effectiveness analysis of buprenorphine-assisted heroin withdrawal
    C M Doran
    School of Population Health, University of Queensland, Herston, Australia
    Drug Alcohol Rev 23:171-5. 2004
    ..These results suggest that the provision of buprenorphine treatment for heroin dependence in shared care and clinic appear to be equally cost-effective...
  5. ncbi Use of pharmacotherapies for the management of addictive behaviours in Australian clinical practice
    Christopher M Doran
    School of Population Health, School of Economics, University of Queensland, Mayne Medical Building, Herston Road, Herston QLD 4006, Australia
    Addict Behav 31:1947-58. 2006
    ..To collect data on the behaviours associated with the prescription of pharmacotherapies (bupropion, acamprosate and naltrexone) for nicotine and alcohol dependence in Australian clinical practice...
  6. ncbi Characteristics of Australian smokers using bupropion and nicotine-replacement therapies
    Christopher Doran
    Associate Professor, School of Economics, University of Queensland School of Population Health Mayne Medical Building, Herston Road, Herston Qld, 4006, Australia
    Expert Rev Pharmacoecon Outcomes Res 7:41-7. 2007
    ....
  7. ncbi Cost-effectiveness analysis of maintenance agonist treatments in the NEPOD
    Christopher M Doran
    Associate Professor, Health Economist, University of Queensland, School of Population Health, School of Economics, Mayne Medical School, Herston Road, Herston 4006, QLD, Australia
    Expert Rev Pharmacoecon Outcomes Res 6:437-46. 2006
    ..Given the limited information available regarding the relative cost-effectiveness of pharmacotherapies for opioid maintenance treatment, the data reported herein provide valuable information to policy makers and treatment providers...
  8. ncbi Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05
    Hera Lutsenko
    School of Population Health, University of Queensland, Australia
    Drug Alcohol Rev 27:160-4. 2008
    ..To compare the usage of bupropion hydrochloride and nicotine replacement in Australia between 2001 and 2005...
  9. ncbi How can we reduce alcohol-related road crash deaths among young Australians?
    Wayne D Hall
    School of Population Health, University of Queensland, Brisbane, QLD, Australia
    Med J Aust 192:464-6. 2010
    ..If we had enforced a zero BAC until age 25, the number of deaths averted until age 25 years could have been as high as 50...
  10. ncbi Cost-effectiveness analysis of genetic screening for the Taq1B polymorphism in the secondary prevention of coronary heart disease
    Linda K Kemp
    The University of Queensland, School of Population Health, Mayne Medical School, Herston Road, Herston 4006, QLD, Australia
    Expert Rev Pharmacoecon Outcomes Res 7:119-28. 2007
    ..Economic evaluations similar to this one will be required in the future as the results of further clinical trials to establish the effectiveness of statins based on genotype become available...
  11. ncbi Cost-effectiveness of interventions to prevent alcohol-related disease and injury in Australia
    Linda Cobiac
    School of Population Health, The University of Queensland, Queensland, Australia
    Addiction 104:1646-55. 2009
    ..To evaluate cost-effectiveness of eight interventions for reducing alcohol-attributable harm and determine the optimal intervention mix...
  12. ncbi Households' willingness to pay for a motorcycle helmet in Hanoi, Vietnam
    Khanh H Pham
    School of Population Health, University of Queensland, Brisbane, Queensland, Australia
    Appl Health Econ Health Policy 6:137-44. 2008
    ..Injuries caused by both non-use of and substandard helmets in motorcycle accidents place a substantial cost on both the Vietnamese government and on victims and their families who are unfortunate enough to experience such an event...
  13. ncbi Tobacco in Australia: still a profitable venture?
    Christopher M Doran
    Aust N Z J Public Health 27:559-60. 2003
  14. ncbi Using taxes to curb drinking in Australia
    Christopher M Doran
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, 2052 NSW, Australia
    Lancet 372:701-2. 2008
  15. ncbi New pharmacotherapies for alcohol dependence: are they being used and what do they cost?
    Christopher M Doran
    Med J Aust 179:218. 2003
  16. ncbi A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial
    Amy E Gibson
    National Drug and Alcohol Research Centre, University of New South Wales, UNSW Randwick Campus, King Street, Randwick, NSW 2052, Australia
    Med J Aust 179:38-42. 2003
    ..To compare outcomes, costs and incremental cost-effectiveness of heroin detoxification performed in a specialist clinic and in general practice...
  17. ncbi Community-based alcohol counselling: a randomized clinical trial
    Anthony P Shakeshaft
    National Drug and Alcohol Research Centre, University of NSW, Sydney, Australia
    Addiction 97:1449-63. 2002
    ..To examine the effectiveness of a brief intervention (BI) and cognitive behaviour therapy (CBT) for alcohol abuse...
  18. ncbi Current prescribing patterns of bupropion in Australia
    Christopher M Doran
    Med J Aust 177:162. 2002
  19. ncbi Economic evaluation of interventions to treat opiate dependence : a review of the evidence
    Christopher M Doran
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    Pharmacoeconomics 26:371-93. 2008
    ..However, to better inform the decision-making process, researchers must continue to produce high-quality, methodological, comparable and scientifically credible economic evaluations...
  20. ncbi Buprenorphine versus methadone maintenance: a cost-effectiveness analysis
    Christopher M Doran
    National Drug and Alcohol Research Centre, University of New South Wales, NSW 2052, Sydney, Australia
    Drug Alcohol Depend 71:295-302. 2003
    ....